ES / EN
- February 2, 2023 -
No Result
View All Result
OnCubaNews Needs You
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home Cuba

Second phase of clinical trials of Cuban Soberana 02 vaccine candidate kicks off

“Everything has gone normally and complying with good practices,” the Finlay Institute reported on Twitter.

by OnCuba Staff, OnCuba editorial staff
December 23, 2020
in Cuba
0
Phase 2 should involve about a hundred people, which will increase to between 300 and 600 in
a phase II-B. Photo: EFE/Archive.

Phase 2 should involve about a hundred people, which will increase to between 300 and 600 in a phase II-B. Photo: EFE/Archive.

After having approved phase 2 of clinical trials of its second vaccine candidate to prevent COVID-19, called Soberana 02, Cuba began vaccinating volunteers, Havana’s Finlay Institute reported this Tuesday.

“This week the vaccination process of the Phase II Clinical Trial of vaccine #Soberana02 began. Everything has gone normally and complying with good practices,” the scientific center dedicated to research and vaccine production reported on Twitter.

Esta semana comenzó el proceso de vacunación del Ensayo Clínico Fase II de la vacuna #Soberana02. Todo ha transcurrido con normalidad y cumpliendo las buenas prácticas. Se evalúa actualmente cuál de las formulaciones de #Soberana01 pasará a la Fase II.#CubaViva en sus #Soberanas pic.twitter.com/RRlOGgP8Tm

— Instituto Finlay (@FinlayInstituto) December 22, 2020

In this Cuban vaccine candidate, the virus antigen and tetanus toxoid are combined, as the director general of the Finlay Vaccine Institute, Vicente Vérez, recently explained. Phase 2 should involve about a hundred people, which will increase to between 300 and 600 in a phase II-B.

Phase 3―more complex to develop on the island due to the low incidence of the disease―should include an even greater number of volunteers. Vérez described this future conjugate vaccine as “innovative” because, he assured, its formulation is unprecedented among all those currently being developed in the world to face SARS-CoV-2.

On December 17, after preliminary positive results of phase I, “Soberana 02″ received authorization from the island’s Center for State Control of Medicines, Equipment and Medical Devices to advance to phase II of clinical trials, which is why it constitutes the first Latin American drug to reach that stage.

Related Posts

Varoufakis participated in the 5th Conference for the Balance of the World, an international forum on foreign relations with more than a thousand participants from 86 countries. Photo: Twitter profile of Yanis Varoufakis.

Yanis Varoufakis in Cuba: the left must recover the concept of freedom

January 30, 2023
Photo: Kaloian.

Right to communication and freedom of the press: notes on a Bill

January 28, 2023
Betsy Remedios performing during the Got Talent finale.

Betsy Remedios after Got Talent: “My goal is not fame, I want to sing”

January 26, 2023
Last position shared by migrants in their social networks. Screenshot.

Cuban migrants manage to survive danger of death on Belarusian border

January 25, 2023

Second phase of Cuban Soberana 02 vaccine candidate’s clinical trials approved

Cuba is developing three other coronavirus vaccine projects, baptized as Soberana 01, Abdala and Mambisa.

The clinical trials of Soberana 01 began at the end of last August, and according to its promoters, the process, which has had the participation of more than 700 volunteers, is progressing without incident.

Unlike other more advanced projects, made from adenoviral vectors or inactivated viruses, this Cuban drug is based on a recombinant protein.

In the case of Abdala (intramuscular) and Mambisa (intranasal), investigated at the Center for Genetic Engineering and Biotechnology (CIGB) in the Caribbean country, it has been announced that clinical trials will begin in which each one will be tested in two phases. Cuba, which has a total of 10,384 positive cases since the beginning of the pandemic and 139 deaths, has a recognized biotechnology and pharmaceutical industry that currently produces eight vaccines against diseases such as meningitis, lung cancer (therapeutic) and solid tumors, among others.

The country’s authorities have indicated that they plan to vaccinate against COVID-19 an “important part” of the Cuban population before the end of the first half of 2021.

EFE/OnCuba

Authors

OnCuba Staff, OnCuba editorial staff
Tags: coronavirus in CubaCuban vaccine against COVID-19Soberana 02
Previous Post

Joe García: “I don’t want to be an ambassador, what I want is to serve my community”

Next Post

Total number of positive cases for coronavirus in Cuba rises to 10,500 after a day of 116 infections

OnCuba Staff

OnCuba Staff

OnCuba Staff

OnCuba Staff

Next Post
Photo: Otmaro Rodríguez/Archive.

Total number of positive cases for coronavirus in Cuba rises to 10,500 after a day of 116 infections

Plaza Cadenas at the University of Havana. Photo: Otmaro Rodríguez/Archive.

Cuban students to get higher monthly stipends

Photo: Otmaro Rodríguez.

Monetary unification: putting accounts in order

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • The Enchanted Shrimp of the Cuban Dance

    1523 shares
    Share 609 Tweet 381
  • Western Union sets up new offices to send remittances to Cuba

    17 shares
    Share 7 Tweet 4
  • What foods can be brought to Cuba and what imports are forbidden?

    388 shares
    Share 155 Tweet 97
  • Yanis Varoufakis in Cuba: the left must recover the concept of freedom

    9 shares
    Share 4 Tweet 2
  • How the U.S. Can Support Cuba’s Emerging Private Sector

    9 shares
    Share 4 Tweet 2

Most Commented

    • About us
    • Work with OnCuba
    • Terms of use
    • Privacy Policy
    • Moderation policy for comments
    • Contact us
    • Advertisement offers

    OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
    OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

    No Result
    View All Result
    • World
    • Cuba
    • Cuba-USA
    • Opinion
      • Columns
      • Infographic
    • Culture
      • Billboard
    • Sports
    • Styles / Trends
    • Media
    • Special
    • Cuban Flavors

    OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
    OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

    Go to mobile version